Pharmacometrics Drug Development Decision Support: Model-Based Meta-Analysis (MBMA) | サターラ

Pharmacometrics Drug Development Decision Support: Model-Based Meta-Analysis (MBMA)

関連コンテンツ

Solving Drug Development Challenges with Model-Based Meta-Analysis (MBMA)

録画ウェビナー

INTERCEPT-AD, a phase 1 study of intravenous sabirnetug in participants with mild cognitive impairment or mild dementia due to Alzheimer’s disease

Preclinical data exposures underpredict clinical physiologically active doses for bispecific T-cell engagers in solid tumors indications; are there better metrics? -insights from a small mechanistic MBMA

A Bird’s Eye View on Rare Diseases: Key Drug Development Considerations for Thyroid Eye Disease

Powered by Translations.com GlobalLink Web Software